omniture
LUNIT INC

Latest News

Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project

* After a successful stage 1, Lunit INSIGHT MMG moves to prospective validation inAustralia's Bre...

2023-12-11 22:30 1742

Lunit to Advance Singapore's Healthcare System with AI-powered Solution for Medical Imaging

* Lunit INSIGHT CXR is piloted at Singapore General Hospital and Changi General Hospital through...

2023-11-30 22:10 1915

AI-Powered TIL Analysis by Lunit Unveils Prognostic Insights for Colon Cancer - published in npj Precision Oncology

* AI-powered spatial analysis of tumor-infiltrating lymphocytes using Lunit SCOPE IO provides acc...

2023-11-27 22:05 1461

Lunit's AI-Powered Mammography Analysis Solution Proves Comparable to Radiologists in Breast Cancer Detection - published in European Radiology

- A large population-based retrospective study in Denmark validates that Lunit INSIGHT MMG's accura...

2023-11-22 22:07 2066

Lunit to Implement AI-Powered Chest Screening Solution in Five Major Saudi Hospitals

-    Lunit brings Lunit INSIGHT CXR to five major Saudi hospitals, aiming to enhance early detectio...

2023-11-16 22:00 1680

Lunit Secures $150 Million in Capital Increase

* Fund fully paid-in as of November 9, achieving over 100% shareholder participation SEOUL, South...

2023-11-15 22:00 1895

Lunit Nets FDA Nod for AI-Powered 3D Breast Tomosynthesis Solution, Lunit INSIGHT DBT

- Lunit INSIGHT DBT receives FDA 510(k) clearance, poised to enter the world's largest DBT market ...

2023-11-14 22:00 1781

Lunit, a Founding Member of CancerX, Showcased in the Inaugural Project to Improve Equity and Reduce Financial Toxicity in Cancer Care

- Lunit INSIGHT suite, Lunit's AI-driven solutions for early detection of cancer, featured in Cance...

2023-11-13 22:00 1455

Lunit to Present Seven AI-Powered Radiology Studies at RSNA 2023

* Two oral presentations and five ePosters accepted by the RSNA: presenting AI advancements for c...

2023-11-06 21:00 1461

AI-Powered Tumor Microenvironment Analysis Predicts Treatment Outcomes in NSCLC Patients with EGFR Mutation: Groundbreaking Studies to be Presented by Lunit at SITC 2023

* Six posters featuring the Lunit SCOPE suite and new insights into the tumor microenvironment ar...

2023-11-01 21:08 1730

Lunit Joins as an Associate Partner with the World Economic Forum

- Lunit joins as an Associate Partner of the World Economic Forum, propelling global expansion and ...

2023-10-31 21:00 1619

Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy

-       Lunit to support MD Anderson researchers studying immune phenotype biomarkers for pembroliz...

2023-10-27 21:07 3170

Lunit Participates in Saudi Vision 2030 Healthcare Sandbox, Accelerating Saudi Arabia's Healthcare Transformation

* Memorandum of Understanding to be inked between Lunit and Seha Virtual Hospital, marking a new ...

2023-10-26 21:00 1389

First Immunotherapy Success in TKI-Resistant Lung Cancer Setting Demonstrates Power of AI-driven Immune Phenotyping by Lunit SCOPE IO - newly published in JCO

* Lunit SCOPE IO pivotal in first phase III trial successfully showing the efficacy of immunother...

2023-10-24 21:00 1609

New Study Demonstrates Lunit SCOPE IO's Effectiveness to Predict Biliary Tract Cancer Therapy Outcomes - Findings to be Presented at the ESMO 2023

- Nine abstracts, featuring the effectiveness of Lunit's AI-powered TIL/WSI analyzer and biomarker ...

2023-10-16 21:10 1563

Lunit to Showcase 9 AI-based Research Results at ESMO 2023

- 9 abstracts accepted by the ESMO annual meeting - unveiling insights into cancer analysis, immuno...

2023-10-10 21:00 1724

Lunit to Reveal 6 Abstracts at the SITC 2023 Annual Meeting

- Lunit's 6 posters unveil new tumor microenvironment insights and the predictive power of Lunit SC...

2023-09-27 22:03 1661

Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening

* Lunit's collaborative study supports AI as a viable alternative to one human reader inEurope's ...

2023-09-12 13:03 2127

Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening

- Lunit's collaborative study supports AI as a viable alternative to one human reader inEurope's do...

2023-09-11 21:00 1789

Lunit Backs the Potential of Tertiary Lymphoid Structures Analysis as an Emerging Biomarker for Lung Cancer Treatment - to be presented at WCLC 2023

- A collaborative study demonstrates that AI analysis of Tertiary Lymphoid Structures (TLS) in tumo...

2023-08-21 21:00 2089